Prophylactic Radiation Therapy Versus Standard of Care for Patients With High-Risk Asymptomatic Bone Metastases: A Multicenter, Randomized Phase II Clinical Trial.
Saved in:
| Title: | Prophylactic Radiation Therapy Versus Standard of Care for Patients With High-Risk Asymptomatic Bone Metastases: A Multicenter, Randomized Phase II Clinical Trial. |
|---|---|
| Authors: | Gillespie EF; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Radiation Oncology, University of Washington, Seattle, WA., Yang JC; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Radiation Oncology, Washington University in St Louis, St Louis, MO., Mathis NJ; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Marine CB; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., White C; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Zhang Z; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Barker CA; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Kotecha R; Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL., McIntosh A; Department of Radiation Oncology, Lehigh Valley Cancer Institute, Allentown, PAa., Vaynrub M; Department of Surgery, Orthopaedic Service, Memorial Sloan Kettering Cancer Center, New York, NY., Bartelstein MK; Department of Surgery, Orthopaedic Service, Memorial Sloan Kettering Cancer Center, New York, NY., Mitchell A; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Guttmann DM; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Yerramilli D; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Higginson DS; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Yamada YJ; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Kohutek ZA; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Radiation Oncology, Vanderbilt University, Nashville, TN., Powell SN; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Tsai J; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Radiation Oncology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, CA., Yang JT; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Radiation Oncology, University of Washington, Seattle, WA. |
| Source: | Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Jan 01; Vol. 42 (1), pp. 38-46. Date of Electronic Publication: 2023 Sep 25. |
| Publication Type: | Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
